Jerry Krishnan to Cost-Benefit Analysis
This is a "connection" page, showing publications Jerry Krishnan has written about Cost-Benefit Analysis.
Connection Strength
0.244
-
Patient registries for home oxygen research and evaluation. Int J Chron Obstruct Pulmon Dis. 2019; 14:1299-1304.
Score: 0.138
-
Omalizumab for severe allergic asthma: dollars and sense. J Allergy Clin Immunol. 2007 Nov; 120(5):1015-7.
Score: 0.062
-
Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017. Respir Med. 2018 10; 143:91-102.
Score: 0.033
-
Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs. Am J Med. 2003 Sep; 115(4):298-308.
Score: 0.012